Hydrocodone restrictions not coming soon, FDA says

Share this article:

Restricting access to hydrocodone painkillers will require a lengthy process unless Congress takes action, the Food and Drug Administration recently told lawmakers.

A bipartisan group of five senators and two representatives wrote to the FDA last month, urging the agency to promptly change hydrocodone painkillers such as Vicodin from Schedule III to Schedule II drugs. To do this, the Drug Enforcement Administration must receive public comment after publishing information about the change in the Federal Register, the FDA said in a March 5 response letter that has been obtained by The Hill. Regulations also require the FDA to conduct further research as part of the reclassifying process, the letter said.

The reclassification, recommended in January by an FDA advisory panel, would make it more difficult to obtain these commonly prescribed medications.

Lawmakers say hydrocodone is fueling a nationwide epidemic of prescription painkiller addiction, but critics say reclassification will make it unnecessarily hard for nursing homes and other healthcare providers to care for those in pain.

The fastest potential route to reclassification would be Congressional legislation mandating the change, the FDA said. A House staffer told The Hill such a bill is pending, but noted 14 years have already passed since Congress first asked the FDA to reclassify hydrocodone.

Share this article:

More in News

Nursing home did not warn worker who was taken hostage in active ...

A nurse at a Life Care Centers of America facility in Colorado was not notified that she would be threatened and taken hostage by a gunman as part of an active shooter drill, according to a lawsuit filed Tuesday.

Revisions to False Claims Act urged by former deputy AG

A panel of witnesses debated the merits of the False Claims Act before a Judiciary subcommittee meeting Wednesday, with one former attorney general arguing current policy provokes unfair litigation and "coercive" settlements.

Medicare SNF rate finalized, reimbursements to increase by $750 million next year

Medicare SNF rate finalized, reimbursements to increase by ...

Medicare skilled nursing facility reimbursements will increase by $750 million next year under a final payment rule announced Thursday by the Centers for Medicare & Medicaid Services.